TiumBio, giving hope to marginalized patients
Summary
TiumBio is a Korean biotech company focused on rare and intractable disease drug candidates. The company plans to license out its pipeline rather than launch drugs itself, with programs in pulmonary fibrosis, endometriosis, hemophilia, and immuno-oncology. It is preparing for a technology-special listing on the KOSDAQ and plans to use IPO proceeds mainly for R&D. The article also outlines its valuation, shareholder structure, and expected milestone revenue from future technology transfer deals.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected